Reply to Marakasova and Baranova, "MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection"
- PMID: 33531392
- PMCID: PMC7858077
- DOI: 10.1128/mBio.03682-20
Reply to Marakasova and Baranova, "MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection"
Comment on
-
Analysis of Measles-Mumps-Rubella (MMR) Titers of Recovered COVID-19 Patients.mBio. 2020 Nov 20;11(6):e02628-20. doi: 10.1128/mBio.02628-20. mBio. 2020. PMID: 33219096 Free PMC article.
-
MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection.mBio. 2021 Feb 2;12(1):e03447-20. doi: 10.1128/mBio.03447-20. mBio. 2021. PMID: 33531391 Free PMC article. No abstract available.
References
-
- Bai Y, Ye L, Tesar DB, Song H, Zhao D, Björkman PJ, Roopenian DC, Zhu X. 2011. Intracellular neutralization of viral infection in polarized epithelial cells by neonatal Fc receptor (FcRn)-mediated IgG transport. Proc Natl Acad Sci U S A 108:18406–18411. doi: 10.1073/pnas.1115348108. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
